Anthony Chang, PhD
About Anthony Chang, PhD
Anthony Chang, PhD, serves as the Chief Executive Officer and Founder of BAMF Health, advocating for intelligence-based precision medicine to improve treatment for neurodegenerative and cardiovascular diseases. He has a robust background in advanced molecular imaging technology and has held significant positions at various prestigious institutions.
Work at BAMF Health
Anthony Chang, PhD, serves as the Chief Executive Officer and Founder of BAMF Health, a position he has held since 2018. Under his leadership, the organization focuses on intelligence-based precision medicine to transform treatment methodologies. Located in the Greater Grand Rapids, Michigan Area, BAMF Health aims to enhance healthcare delivery, particularly for neurodegenerative and cardiovascular diseases, through innovative technological solutions.
Education and Expertise
Anthony Chang holds a PhD in Medical Physics from UT Health San Antonio, where he studied from 2004 to 2009. He also completed a Biomedical Engineering program at Vanderbilt University from 2002 to 2004. Earlier, he earned a Bachelor of Science in Medical Imaging and Radiological Sciences from Chang Gung University from 1997 to 2001. His educational background supports his expertise in integrating advanced molecular imaging technology with artificial intelligence, particularly in cancer care.
Background
Prior to his role at BAMF Health, Anthony Chang worked at the Van Andel Institute from 2010 to 2016. During this time, he held multiple positions, including Head of the Laboratory of Translational Imaging and Founding Director of the Small Animal Imaging Facility. He also served as a Research Assistant Professor. Earlier in his career, he was a Special Graduate Student and Research Assistant at the Vanderbilt University Institute of Imaging Science from 2002 to 2004.
Achievements
Anthony Chang has pioneered the integration of advanced molecular imaging technology with artificial intelligence to enhance precision medicine in cancer care. His work focuses on improving patient outcomes by creating more personalized and meaningful experiences for patients and their families. His advocacy for intelligence-based precision medicine aims to revolutionize treatment approaches in healthcare.